WeFund Ventures

WeFund Ventures is a venture capital firm established in 2017 and headquartered in Tallinn, Estonia, with an additional office in Berlin, Germany. The firm specializes in early-stage investments across various sectors, including agritech, fintech, blockchain, security, biotech, enterprise solutions, big data, augmented reality/virtual reality, and aerospace. WeFund Ventures operates an acceleration fund that provides financing to very early-stage projects, utilizing an efficient syndicate funding structure that enhances its ability to mobilize substantial resources quickly and flexibly. The firm aims to support promising projects and drive innovation in its targeted industries.

Alex Glotov

Partner

Dmytro Ruzhytskyi

Partner

Alex Skubenko

CEO

2 past transactions

Payris

Seed Round in 2019
Payris is an ecosystem where customers publish their wishes and businesses complete them. Using Payris, consumer can publish a wish, get connected to a supplier who can complete the wish, and get rewarded for making their wishes come true through the app. Vendors may use Payris to buy hot leads and data for research. The platform tackles and solves the problem of social networks collecting and exploiting user data for free – Payris rewards users for sharing their wishes and completing surveys.

A.D.A.M.

Seed Round in 2018
A.D.A.M. is a 3D bioprinting startup focused on developing a Point-of-Care Medical Device Production System specifically for bone implants. The company aims to revolutionize the medical field by providing hospitals with the capability to produce personalized, bio-resorbable, and biodegradable implants in-house, significantly reducing costs and time associated with traditional manufacturing processes. A.D.A.M.'s turnkey system, which can be installed and operational within three months, combines proprietary printing technology, materials, and software to streamline the production of custom implants. This innovative approach contrasts sharply with the existing market, where hospitals face high setup costs and lengthy timelines for establishing their own 3D printing capabilities. By offering a subscription-based service model, A.D.A.M. not only lowers operational expenses but also facilitates scalability across different healthcare settings. The company has established partnerships with notable institutions, enhancing its market strategy and positioning as a leader in on-demand personalized tissue manufacturing.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.